Tripos Halts Sale Of Chemistry Arm | Chemical & Engineering News
Volume 85 Issue 10 | p. 29 | Concentrates
Issue Date: March 5, 2007

Tripos Halts Sale Of Chemistry Arm

Department: Business

Tripos has ended an agreement to sell its U.K.-based Discovery Research business to Provid Pharmaceuticals for $2 million (C&EN, Jan. 8, page 29) after Provid failed to provide a financing commitment letter. Tripos says it will work to restructure the transaction with Provid but also will talk with other interested parties. The sale is the second step in Tripos' dissolution as a publicly traded company. Late last year, Tripos announced the sale of its Discovery Informatics business to Vector Capital for $25.6 million.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment